181 related articles for article (PubMed ID: 25526438)
1. Prior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis.
Abd Elrazek AE; Bilasy SE; Elbanna AEM; Elsherif AEA
Medicine (Baltimore); 2014 Dec; 93(28):e204. PubMed ID: 25526438
[TBL] [Abstract][Full Text] [Related]
2. Incidence of HCV induced-Esophageal varices in Egypt: Valuable knowledge using data mining analysis.
Abdel-Aty M; Fouad M; Sallam MM; Elgohary EA; Ismael A; Nawara A; Hawary B; Tag-Adeen M; Khaled S
Medicine (Baltimore); 2017 Jan; 96(4):e5647. PubMed ID: 28121921
[TBL] [Abstract][Full Text] [Related]
3. Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.
Waked I; Shiha G; Qaqish RB; Esmat G; Yosry A; Hassany M; Soliman R; Mohey MA; Allam N; Zayed N; Asselah T; Hall C; Redman R; Mobashery N; Doss W
Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):36-44. PubMed ID: 28404110
[TBL] [Abstract][Full Text] [Related]
4. Effect of schistosomiasis and hepatitis on liver disease.
Halim AB; Garry RF; Dash S; Gerber MA
Am J Trop Med Hyg; 1999 Jun; 60(6):915-20. PubMed ID: 10403320
[TBL] [Abstract][Full Text] [Related]
5. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.
Kamal S; Madwar M; Bianchi L; Tawil AE; Fawzy R; Peters T; Rasenack JW
Liver; 2000 Jul; 20(4):281-9. PubMed ID: 10959806
[TBL] [Abstract][Full Text] [Related]
6. Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study.
Said M; Soliman Z; Daebes H; M El-Nahaas S; El-Serafy M
Expert Rev Gastroenterol Hepatol; 2019 Dec; 13(12):1189-1195. PubMed ID: 31702417
[No Abstract] [Full Text] [Related]
7. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
[TBL] [Abstract][Full Text] [Related]
8. Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.
Mangia A; Susser S; Piazzolla V; Agostinacchio E; De Stefano G; Palmieri V; Spinzi G; Carraturo I; Potenza D; Losappio R; Arleo A; Miscio M; Santoro R; Sarrazin C; Copetti M
J Hepatol; 2017 Apr; 66(4):711-717. PubMed ID: 27965158
[TBL] [Abstract][Full Text] [Related]
9. Predictors of sustained virological response in Greek and Egyptian patients with hepatitis C genotype 4: does ethnicity matter?
Papastergiou V; Dimitroulopoulos D; Skorda L; Lisgos P; Ketikoglou I; Kostas N; Karatapanis S
J Med Virol; 2012 Aug; 84(8):1217-23. PubMed ID: 22711349
[TBL] [Abstract][Full Text] [Related]
10. Sustained virological response: a milestone in the treatment of chronic hepatitis C.
Morisco F; Granata R; Stroffolini T; Guarino M; Donnarumma L; Gaeta L; Loperto I; Gentile I; Auriemma F; Caporaso N
World J Gastroenterol; 2013 May; 19(18):2793-8. PubMed ID: 23687416
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.
Sagnelli E; Stroffolini T; Sagnelli C; Cacopardo B; Andriulli A; Babudieri S; Coppola N; Gaeta GB; Almasio PL
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):676-681. PubMed ID: 29465473
[TBL] [Abstract][Full Text] [Related]
12. Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence.
Gad A; Tanaka E; Matsumoto A; el-Hamid Serwah A; Ali K; Makledy F; el-Gohary A; Orii K; Ijima A; Rokuhara A; Yoshizawa K; Nooman Z; Kiyosawa K
J Med Virol; 2003 Aug; 70(4):594-9. PubMed ID: 12794722
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis C in Asia: when East meets West.
Yu ML; Chuang WL
J Gastroenterol Hepatol; 2009 Mar; 24(3):336-45. PubMed ID: 19335784
[TBL] [Abstract][Full Text] [Related]
15. NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients.
El-Shamy A; Shoji I; El-Akel W; Bilasy SE; Deng L; El-Raziky M; Jiang DP; Esmat G; Hotta H
J Clin Microbiol; 2012 Dec; 50(12):3886-92. PubMed ID: 22993188
[TBL] [Abstract][Full Text] [Related]
16. Viral hepatitis C infection among Egyptians the magnitude of the problem: epidemiological and laboratory approach.
Mohamed MK; Rakhaa M; Shoeir S; Saber M
J Egypt Public Health Assoc; 1996; 71(1-2):79-111. PubMed ID: 17217003
[TBL] [Abstract][Full Text] [Related]
17. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
[TBL] [Abstract][Full Text] [Related]
18. Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection.
Udompap P; Mannalithara A; Heo NY; Kim D; Kim WR
J Hepatol; 2016 May; 64(5):1027-1032. PubMed ID: 26809112
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.
Roulot D; Bourcier V; Grando V; Deny P; Baazia Y; Fontaine H; Bailly F; Castera L; De Ledinghen V; Marcellin P; Poupon R; Bourlière M; Zarski JP; Roudot-Thoraval F;
J Viral Hepat; 2007 Jul; 14(7):460-7. PubMed ID: 17576387
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.
Bert F; Rindermann A; Abdelfattah MA; Stahmeyer JT; Rossol S
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1246-52. PubMed ID: 27439034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
